Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn's disease and ulcerative colitis: 2-year results from open-label extensions of two randomized controlled trials (LIBERTY)
皮下注射英夫利昔单抗（CT-P13 SC）作为克罗恩病和溃疡性结肠炎的维持治疗：两项随机对照试验开放标签扩展研究的 2 年结果（LIBERTY）
期刊:Journal of Crohns & Colitis
影响因子:8.7
doi:10.1093/ecco-jcc/jjaf060
Colombel, Jean-Frederic; Sandborn, William J; Schreiber, Stefan; Danese, Silvio; Kłopocka, Maria; Kierkuś, Jarosław; Kulynych, Roman; Gonciarz, Maciej; Sołtysiak, Artur; Smoliński, Patryk; Srećković, Slobodan; Valuyskikh, Ekaterina; Lahat, Adi; Horyński, Marek; Gasbarrini, Antonio; Osipenko, Marina; Borzan, Vladimir; Kowalski, Maciej; Saenko, Daria; Sardinov, Ruslan; Lee, Sang Joon; Kim, Sunghyun; Bae, Yunju; Lee, Sunhee; Lee, Seulgi; Lee, Joon Ho; Kim, Jong Min; Park, Gahee; Lee, Jimin; Lee, Juhyun; Ryu, Jae Yeoul; Sands, Bruce E; Hanauer, Stephen B
